Concepedia

Publication | Open Access

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

524

Citations

41

References

2016

Year

Abstract

These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.

References

YearCitations

Page 1